SCHEMBL23609934

SCHEMBL23609934

Clc1nc(-c2cccc3c2oc2c4ccccc4ccc32)c2ccccc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A1 P04798 10/20 0.41
CYP1A2 P05177 10/20 0.41
CYP1B1 Q16678 10/20 0.41
ARSA P15289 1/20 0.38
CDC25A P30304 1/20 0.38
CDC25C P30307 1/20 0.38
ADORA2A P29274 1/20 0.36
HPGD P15428 2/20 0.36
CYP3A4 P08684 2/20 0.36
TSHR P16473 2/20 0.36
CYP2C19 P33261 2/20 0.36
PRKDC P78527 2/20 0.36
MAPT P10636 2/20 0.36
PDE5A O76074 1/20 0.36
TP53 P04637 1/20 0.36
ABCB1 P08183 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18456304 0.86 KDM4E (0.49) KDM4EALDH1A1ADORA2AHPGDPRKDC
SCHEMBL23609708 0.86 KDM4E (0.41) KDM4EALDH1A1CYP1A1CYP1A2CYP1B1
SCHEMBL22894076 0.84 ALDH1A1 (0.42) KDM4EALDH1A1CYP1A1CYP1A2ADORA2A
SCHEMBL14233141 0.83 KDM4E (0.46) KDM4EALDH1A1ADORA2APRKDCMAPT
SCHEMBL22698060 0.82 KDM4E (0.44) KDM4EALDH1A1ADORA2APRKDCMAPT
SCHEMBL23609928 0.82 ALDH1A1 (0.42) KDM4EALDH1A1CYP1A2ADORA2AHPGD
SCHEMBL29572574 0.81 ALDH1A1 (0.54) KDM4EALDH1A1CYP1A2ADORA2AHPGD
SCHEMBL15860268 0.81 ALDH1A1 (0.54) KDM4EALDH1A1CYP1A2ADORA2AHPGD
SCHEMBL22697721 0.80 KDM4E (0.40) KDM4EALDH1A1ADORA2AHPGDPRKDC
SCHEMBL21147081 0.78 KDM4E (0.50) KDM4EALDH1A1CYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411411-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT LT MATERIALS CO.,LTD. (KR) 2022-12-29 US disclosed
WO-2021133016-A2 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT 엘티소재주식회사 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411411-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT CRY1, ODC1, ORC3 KDM4E 2970/4885ALDH1A1 53/4885CYP1A1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.